세계의 근시 및 노안 치료 시장 보고서(2025년)
Myopia and Presbyopia Treatment Global Market Report 2025
상품코드 : 1821648
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

근시 및 노안 치료 시장의 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.3%로 311억 7,000만 달러로 성장할 전망입니다. 예측기간의 성장은 안질환에 대한 유전자 치료의 출현, 라이프스타일 향상을 위한 시력 교정에 대한 주목, 오르소케라톨로지의 채용 확대, 눈과 관련된 습관에 영향을 주는 문화적 요인, 예방적 안과로의 시프트 등에 기인할 것으로 예측됩니다. 예측기간의 주요 동향으로는 시력 관리를 위한 원격의료, 약물 개입, 맞춤형 콘택트렌즈, 근시 억제 장치, 고도 안구내 렌즈(IoLS), 노안용 굴절 교정 수술, 렌즈 이식 기술 등이 있습니다.

향후 5년간의 예측 성장률 8.3%는 과거 예측에서 0.1% 감소한 수치입니다. 이러한 성장세 둔화는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세장벽은 스위스나 일본에서 수입되는 다초점 안구내 렌즈 및 오르소케라톨로지 렌즈의 비용을 상승시키고, 굴절 교정의 선택을 제한하며, 안과 진료 비용을 상승시킴으로써 미국의 안과 시장을 저해할 것으로 예측됩니다. 이 영향은 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 부정적인 영향으로 더욱 확산될 것으로 예상됩니다.

노년 인구 가운데 특히 65세 이상의 인구 증가가 예측되어 근시 및 노안 치료 시장의 성장을 가속할 것으로 예측됩니다. 이 인구층은 노화와 관련된 취약성과 면역력의 저하로 근시와 노안 등 눈과 관련된 질병의 위험이 높아지고 있습니다. 이러한 질병을 대상으로 한 치료에는 종종 눈의 시각적 및 현미경을 사용한 철저한 검사가 포함되며, 노인들 사이에서 유행하는 다양한 눈 관련 질환을 확인하고 관리하는 데 도움이 됩니다. 세계보건기구(WHO)의 2022년 10월 보고서에 따르면 2030년까지 세계 6명 중 1명이 60세 이상이 될 전망이며, 2050년까지 세계의 60세 이상 인구는 21억 명에 이를 것으로 추정됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Myopia and presbyopia treatment encompasses procedures or therapies aimed at rectifying and enhancing vision affected by myopia and presbyopia, both in adults and children. The primary objective revolves around diagnosing underlying conditions, mitigating injury risks, alleviating ocular symptoms, and early detection of these eye conditions.

The main focus of myopia and presbyopia treatment is on two specific eye conditions such as myopia and presbyopia. Myopia involves visual images focusing in front of the retina, resulting in reduced clarity when viewing distant objects. Treatments for myopia cater to both adults and children, encompassing corrective measures, surgical interventions, and pharmaceutical approaches. On the other hand, presbyopia treatment methods comprise prescription lenses, contact lenses, intraocular lenses, and refractive surgeries, specifically targeting presbyopia-related visual impairments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The myopia and presbyopia treatment market research report is one of a series of new reports from The Business Research Company that provides myopia and presbyopia treatment market statistics, including myopia and presbyopia treatment industry global market size, regional shares, competitors with a myopia and presbyopia treatment market share, detailed myopia and presbyopia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the myopia and presbyopia treatment industry. This myopia and presbyopia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The myopia and presbyopia treatment market size has grown strongly in recent years. It will grow from $21.04 billion in 2024 to $22.63 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing prevalence of myopia and presbyopia, awareness and education initiatives, shift in lifestyles and screen time, consumer preference for non-surgical treatments, economic growth and healthcare spending, clinical research and development, accessibility to eyecare services.

The myopia and presbyopia treatment market size is expected to see strong growth in the next few years. It will grow to $31.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to emergence of gene therapies for eye disorders, focus on vision correction for lifestyle enhancement, growing adoption of orthokeratology, cultural factors impacting eyecare practices, shift towards preventive eyecare. Major trends in the forecast period include telemedicine for vision care, pharmaceutical interventions, customized contact lenses, myopia control devices, advanced intraocular lenses (IoLS), refractive surgery for presbyopia, and lens implant technologies.

The forecast of 8.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. vision care market by increasing the cost of multifocal intraocular lenses and orthokeratology lenses imported from Switzerland and Japan, thereby reducing refractive correction options and elevating ophthalmology practice costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The projected rise in the geriatric population, specifically individuals aged 65 and above, is anticipated to propel the growth of the myopia and presbyopia treatment market. This demographic segment, due to age-related vulnerabilities and lowered immunity, experiences heightened risks of eye-related ailments, including myopia and presbyopia. Treatments targeting these conditions often involve thorough examination of the visual and microscopic elements of the eye, aiding in the identification and management of various eye-related illnesses prevalent among the elderly. According to the World Health Organization's October 2022 report, by 2030, one in six individuals globally will be 60 or older, and by 2050, the worldwide population aged 60 or above is estimated to reach 2.1 billion, indicating a substantial surge in demand for treatments addressing age-related vision issues.

The escalating incidence of vision impairment is poised to drive growth in the myopia and presbyopia treatment market. Vision impairment, characterized by reduced visual interpretative abilities, poses challenges in perceiving and comprehending the surrounding environment. This trend is anticipated to spur the development of treatments, encouraging heightened awareness, innovation, and investments in the field. Notably, a report from the Centers for Disease Control and Prevention in August 2023 highlights a projected increase in vision impairment cases to 8.96 million by 2050 in the United States. Factors contributing to this rise include the prevalence of chronic diseases like diabetes and an aging population. Moreover, approximately 6.8% of children under 18 in the U.S. have been diagnosed with eye and vision issues, emphasizing the need for effective solutions catering to various age groups experiencing visual challenges.

Technologically advanced solutions are a key trend gaining traction in the myopia and presbyopia treatment market. Major companies are focusing on developing innovative solutions to maintain their competitive edge. For instance, in September 2024, Entod Pharmaceuticals, an India-based manufacturing company, launched PresVu Eye Drops, marking the first eye drop in India specifically formulated for treating presbyopia, a common age-related vision condition that typically affects individuals over 40 years old. Approved by the Drug Controller General of India (DCGI), PresVu is designed to reduce the reliance on reading glasses while providing lubrication to the eyes. These eye drops employ advanced dynamic buffer technology, ensuring consistent efficacy and safety for prolonged use.

Companies in the myopia and presbyopia treatment sector are innovating products, such as myopia-combating sun spectacle lenses, to broaden their customer base and drive revenue growth. Notably, in May 2023, HOYA launched MiYOSMART sun spectacle lenses, designed to mitigate myopia progression in children. These lenses, incorporating DIMS Technology, offer specialized options like MiYOSMART Chameleon and MiYOSMART Sunbird, aiming to slow myopia progression while providing sunlight protection. This technology, developed in collaboration with the Hong Kong Polytechnic University, introduces defocus elements to regulate myopia progression during outdoor activities. The market's emphasis on innovation aligns with emerging evidence supporting outdoor time as a preventive measure against myopia, emphasizing the significance of encouraging outdoor engagements for myopic children.

In January 2024, Eyenovia Inc., a US-based ophthalmic pharmaceutical technology company, acquired the development and commercialization rights for MicroPine from Bausch + Lomb Ireland Limited for an undisclosed amount. The purpose of this acquisition is to accelerate the commercialization of advanced ophthalmic products, specifically aimed at treating pediatric progressive myopia, thus enhancing their late-stage pipeline and addressing a significant unmet medical need in the U.S. and Canada. Bausch + Lomb Ireland Limited is an Ireland-based eye health company involved in the development of MicroPine for myopia treatment.

Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Hagg Striet UK Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., Regeneron Pharmaceuticals Inc., Sydnexis Inc., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Novartis AG, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, Ophthotech Corporation, OphthaliX Inc., LensGen Inc., Lightico Ltd., RxSight Inc., Perfect Lens LLC

North America was the largest region in the myopia and presbyopia treatment market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the myopia and presbyopia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The myopia and presbyopia treatment market includes revenues earned by entities by performing refractive surgery, lens implants, bifocal surgery services and providing eye sight management treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Myopia and Presbyopia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on myopia and presbyopia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for myopia and presbyopia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The myopia and presbyopia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Myopia and Presbyopia Treatment Market Characteristics

3. Myopia and Presbyopia Treatment Market Trends And Strategies

4. Myopia and Presbyopia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Myopia and Presbyopia Treatment Growth Analysis And Strategic Analysis Framework

6. Myopia and Presbyopia Treatment Market Segmentation

7. Myopia and Presbyopia Treatment Market Regional And Country Analysis

8. Asia-Pacific Myopia and Presbyopia Treatment Market

9. China Myopia and Presbyopia Treatment Market

10. India Myopia and Presbyopia Treatment Market

11. Japan Myopia and Presbyopia Treatment Market

12. Australia Myopia and Presbyopia Treatment Market

13. Indonesia Myopia and Presbyopia Treatment Market

14. South Korea Myopia and Presbyopia Treatment Market

15. Western Europe Myopia and Presbyopia Treatment Market

16. UK Myopia and Presbyopia Treatment Market

17. Germany Myopia and Presbyopia Treatment Market

18. France Myopia and Presbyopia Treatment Market

19. Italy Myopia and Presbyopia Treatment Market

20. Spain Myopia and Presbyopia Treatment Market

21. Eastern Europe Myopia and Presbyopia Treatment Market

22. Russia Myopia and Presbyopia Treatment Market

23. North America Myopia and Presbyopia Treatment Market

24. USA Myopia and Presbyopia Treatment Market

25. Canada Myopia and Presbyopia Treatment Market

26. South America Myopia and Presbyopia Treatment Market

27. Brazil Myopia and Presbyopia Treatment Market

28. Middle East Myopia and Presbyopia Treatment Market

29. Africa Myopia and Presbyopia Treatment Market

30. Myopia and Presbyopia Treatment Market Competitive Landscape And Company Profiles

31. Myopia and Presbyopia Treatment Market Other Major And Innovative Companies

32. Global Myopia and Presbyopia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Myopia and Presbyopia Treatment Market

34. Recent Developments In The Myopia and Presbyopia Treatment Market

35. Myopia and Presbyopia Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기